A PHASE 2, MULTICENTER, RANDOMIZED, DOUBLE-BLIND,PLACEBO-CONTROLLED STUDY IN PEDIATRIC SUBJECTS WITHPEANUT ALLERGY TO EVALUATE THE EFFICACY AND SAFETY OFDUPILUMAB AS ADJUNCT TO AR101 (PEANUT ORALIMMUNOTHERAPY

Project: Research project

Project Details

StatusActive
Effective start/end date1/23/20 → 8/31/50

Funding

  • Regeneron Pharmaceuticals, Inc.